Hematology/Oncology

Top Story

Interaction between prostate cancer, comorbidities increases VTE risk

August 4, 2015

High levels of comorbidities considerably increased venous thromboembolism risk among patients with prostate cancer, according to results of a national cohort study.

The clinical interaction between prostate cancer and those comorbidities accounted for nearly one-third of VTEs among that patient population, results showed. Consequently, the ability to reduce VTEs associated with comorbidities may help improve the prognosis of patients with prostate cancer, researchers wrote.

FDA News

FDA grants orphan drug designation to veltuzumab for ITP

August 4, 2015
The FDA granted orphan drug designation to veltuzumab — a humanized anti-CD20 antibody — for the treatment of patients with immune thrombocytopenia…
In the Journals

Urine biomarkers accurately identify early-stage pancreatic cancer

August 4, 2015
Researchers have developed a three-biomarker panel that can detect early-stage pancreatic ductal adenocarcinoma through urine analysis, which could lead to a noninvasive…
Rita F. Redberg, MD, MSc In the Journals

Surrogate endpoints may not predict OS in oncology clinical trials

August 4, 2015
A majority of trial-level validation studies of surrogate endpoints demonstrated little correlation with survival rates, according to a systematic review of trial-level…
Hatem A. Azim, Jr., MD In the Journals

Assisted reproduction feasible for women with breast cancer history

August 4, 2015
Women with a history of breast cancer can utilize assisted reproductive technology to become pregnant without any detriment to their cancer outcome, according to study…
More News Headlines »
CME
Immunotherapy Updates 2015: FOCUS on NSCLC

Immunotherapy Updates 2015: FOCUS on NSCLC

This activity is supported by educational grants from Genentech, Inc. and Merck & Co., Inc.

Globally, lung cancer is the leading cause of cancer-related deaths. Non-small cell lung cancer (NSCLC) accounts for…
More »
Meeting News Coverage Video
VIDEO: 'Care paths' may help manage rising cancer costs

VIDEO: 'Care paths' may help manage rising cancer costs

June 19, 2015
CHICAGO — Brian Bolwell, MD, chairman of Taussig Cancer Institute at Cleveland Clinic, discusses an abstract on…
More »
Tailored Therapies for Myelodysplastic Syndromes

Tailored Therapies for Myelodysplastic Syndromes

This activity is supported by an educational grant from Celgene Corporation.

Myelodysplastic syndromes (MDS) represent a group of myeloid clonal hemopathies with heterogeneous clinical…
More »
morganatic-roan
morganatic-roan